Option chain shows key data for CalciMedica's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for CalciMedica.

CalciMedica (NASDAQ:CALC) Stock, Option Chain

CalciMedica

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

CALC


Small-cap stocks are more important than ever. The combined forces of falling interest rates and business-friendly presidential policies are expected to create economic tailwinds in 2025 and a broadening stock market

Insiders Bet Big on These Small Cap Stocks

Carvana

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATEC

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

CPSH

CVNA

DAWN

EFSH

ELAB

ENSC

LUXH

MDJH

RDDT

RELY

ROKU

ROOT

Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

I53 Investments Since 2017

Short Ideas

Insider Trades

AULT

ZVIA

Standard BioTools And 2 Other Penny Stocks Executives Are Buying

CalciMedica Inc

Calcitech Ltd

Calcol Inc

Offerings

Press Releases

CalciMedica Announces Pricing of Public Offering of Common Stock

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

Earnings

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

CalciMedica Secures Credit Facility for Up to $32.5 Million

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

AN2 Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Cara Therapeutics

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cocrystal Pharma

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Durect

Grace Therapeutics

Hoth Therapeutics

IGC Pharma

Opus Genetics

Iterum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lexaria Bioscience

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

OptiNose

Pulmatrix

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

SCYNEXIS

VYNE Therapeutics

HC Wainwright & Co.

LUCID CAPITAL MARKETS

Oppenheimer

JonesTrading

Comments

CalciMedica

CalciMedica (CALC) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga